Nifedipine is primarily known as a calcium channel blocker used to treat high blood pressure. In obstetric practice across Nigeria, it serves a different life-saving purpose: acting as a tocolytic agent to halt preterm labor. Midwives rely on tocolytics to buy crucial time when a pregnant woman experiences premature contractions before fetal lungs are fully developed. By delaying delivery for 48 hours, healthcare teams can administer antenatal corticosteroids, such as dexamethasone, to significantly improve neonatal survival rates. Compared to older tocolytics like ritodrine or magnesium sulfate, nifedipine is widely favored because it is taken by mouth, causes fewer severe side effects for the mother, and is remarkably affordable for patients in resource-limited settings.
To understand how nifedipine stops contractions, look at the muscle cells of the myometrium. Smooth muscle contraction requires an influx of calcium ions into the cells to trigger the interaction between actin and myosin. Nifedipine blocks L-type voltage-gated calcium channels on the cell membrane. Preventing calcium from entering keeps the intracellular concentration low, stopping the myometrial fibers from shortening. Because the drug acts broadly on smooth muscle, it relaxes not only the uterus but also blood vessels, which explains why a mother's blood pressure can drop while she is taking it.
Nifedipine is indicated when a patient presents with regular uterine contractions and progressive cervical change between 24 and 34 weeks of gestation. The main goal of this therapy is not to halt labor indefinitely, but rather to achieve a temporary delay. This brief window allows for safe maternal transfer to a tertiary facility with a functional neonatal intensive care unit and ensures time for completed doses of corticosteroids. Midwives must confirm true preterm labor before starting treatment, as false labor contractions do not require tocolysis.
For tocolysis, oral administration is standard, avoiding the need for complex intravenous pumps.
Midwives must ensure immediate-release tablets are used for the loading dose, as sustained-release formulas do not absorb quickly enough to stop active labor contractions.
Because nifedipine relaxes smooth muscle throughout the body, side effects are an extension of its vascular action. Mothers frequently complain of facial flushing, warm sensations, headaches, and dizziness due to peripheral vasodilation. A transient drop in maternal blood pressure is expected, which requires careful monitoring so it does not compromise uteroplacental blood flow. Fetal well-being is generally preserved because the drug maintains adequate placental perfusion, provided maternal blood pressure does not plummet excessively.
Not every woman experiencing preterm contractions is a candidate for nifedipine. Midwives must screen patients thoroughly before administering the first dose.
Safe administration of nifedipine requires rigorous bedside observation. Before every single dose is given, the midwife must check and record the mother's blood pressure and pulse rate. If the systolic blood pressure drops below 90 mmHg or the pulse exceeds 120 beats per minute, the dose must be withheld and the doctor notified. Additionally, continuous or intermittent fetal heart rate monitoring must be maintained to ensure the baby tolerates the reduction in uterine activity. Fluid intake and output should be tracked to prevent fluid overload, especially if corticosteroids are running concurrently.